LATEST TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR PARTIAL ONSET OF SEIZURES

被引：0
|
作者：
Aggarwal, S. [1 ]
Kumar, S. [2 ]
Topaloglu, H. [1 ]
机构：
[1] NOVEL Hlth Strategies, Chevy Chase, MD USA
[2] Inst Global Policy Res, Washington, DC USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM181
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 50 条
  • [21] EFFICACY OF LACOSAMIDE IN PARTIAL-ONSET SEIZURES WITH AND WITHOUT SECONDARY GENERALIZATION: A POOLED ANALYSIS OF THREE PHASE II/III TRIALS
    Isojarvi, J.
    Rosenow, F.
    Faught, R.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 112 - 112
  • [22] Lacosamide Efficacy in Partial-Onset Seizures with and without Secondary Generalization: A Pooled Analysis of Three Phase II/III Trials
    Isojarvi, Jouko
    Rosenow, Felix
    Taught, Raymond Edward
    Hebert, David
    Doty, Pamela
    ANNALS OF NEUROLOGY, 2009, 66 : S14 - S15
  • [23] Evaluation of Lacosamide Efficacy in Subjects with Difficult-to-Treat Partial-Onset Seizures across the Dose Range Used in Phase II/III Clinical Trials
    Chung, Steve
    Rudd, G. David
    Hebert, David
    Doty, Pamela
    NEUROLOGY, 2009, 72 (11) : A352 - A352
  • [24] Review of US clinical trials of zonisamide in treatment of refractory partial-onset seizures
    Faught, E
    EPILEPSIA, 1999, 40 : 94 - 95
  • [25] Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials
    Slater, Jeremy
    Chung, Steve
    Huynh, Lynn
    Duh, Mei Sheng
    Gorin, Brian
    McMicken, Carolyn
    Ziemann, Adam
    Isojarvi, Jouko
    EPILEPSY RESEARCH, 2018, 143 : 120 - 129
  • [26] Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate
    Cramer, Joyce A.
    Velez, Fulton F.
    Anastassopoulos, Kathryn P.
    Bond, T. Christopher
    Gilliam, Frank G.
    Ryvlin, Philippe
    Specchio, Luigi M.
    Wang, Xuezhe
    Blum, David
    Moreira, Joana
    Rocha, Francisco
    EPILEPSY & BEHAVIOR, 2015, 53 : 149 - 153
  • [27] Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures
    Andermann, Eva
    Biton, Victor
    Benbadis, Selim R.
    Shneker, Bassel
    Shah, Aashit K.
    Carreno, Mar
    Trinka, Eugen
    Ben-Menachem, Elinor
    Biraben, Arnaud
    Rocha, Francisco
    Gama, Helena
    Cheng, Hailong
    Blum, David
    EPILEPSY & BEHAVIOR, 2018, 82 : 119 - 127
  • [28] Global Phase III Trials of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
    French, Jacqueline
    Elger, Christian
    Goldberg-Stern, Hadassa
    Thomson, Alfredo
    Krauss, Gregory L.
    Squillacote, David
    Yang, Haichen
    Kumar, Dinesh
    NEUROLOGY, 2011, 76 (09) : A376 - A376
  • [29] Adjunctive perampanel 4 mg/day for focal-onset seizures (FOS): Time to seizure onset in pivotal phase III studies
    Salah, Alejandro
    Patten, Anna
    Malhotra, Manoj
    EPILEPSIA, 2021, 62 : 42 - 43
  • [30] Latest trends in cancer clinical trials using genomics
    Ryu, Hyewon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (12): : 716 - 725
12345